Top 7 U.S. Biomaterials Engineering Companies Advancing Injectable and Self-Healing Hydrogels

---

Hydrogels—three-dimensional, water-swollen polymer networks—are rapidly advancing the frontiers of biomedicine. Especially promising are injectable and self-healing hydrogels, which allow for minimally invasive delivery, in situ gelling, and adaptive responses to mechanical or biochemical stimuli.

Whether used for drug delivery, tissue regeneration, cell encapsulation, or hemostatic therapy, hydrogels are critical tools in today’s biomedical engineering arsenal.

In this article, we highlight seven leading U.S.-based companies that are redefining what hydrogels can do. These innovators are turning fluid materials into dynamic, smart structures that can heal, protect, and deliver therapy with precision.

---

1. LynkDx Inc.

Headquarters: Baltimore, MD (Johns Hopkins spinout)

🔬 Main Product Line:

• Proprietary injectable hydrogel platform designed for biomarker detection and controlled delivery in gynecologic applications

✅ Pros:

• The hydrogel matrix is engineered to interact with epithelial tissues and bind disease-specific biomarkers—especially useful in cancer diagnostics.
• Biodegradable and minimally invasive for internal applications.
• In development for diagnostic use in ovarian and endometrial cancers.

📈 Future Growth Prospects:

LynkDx’s hydrogel platform is uniquely positioned at the intersection of precision diagnostics and biomaterials. With growing interest in non-invasive and patient-friendly diagnostics, its technology is likely to see clinical expansion and partnerships.

---

2. Cresilon Inc.

Headquarters: Brooklyn, NY

🔬 Main Product Line:

• VETIGEL® – Injectable self-healing hydrogel designed to stop bleeding instantly
• Made from plant-based polysaccharides

✅ Pros:

• Forms a strong mechanical barrier in seconds by conforming to tissue and initiating clotting, without requiring external pressure.
• Injected directly into wounds—ideal for trauma, surgery, or emergency medicine.
• Biocompatible and resorbable.

📈 Future Growth Prospects:

Initially targeted at veterinary markets, Cresilon is moving toward FDA approval for human use, including battlefield and civilian trauma care. The self-healing and fast-setting properties give it an edge in acute care and surgical hemostasis markets.

---

3. Allevi (3D Systems)

Headquarters: Philadelphia, PA

🔬 Main Product Line:

• Bioinks and hydrogel kits for bioprinting, including photo-crosslinkable gelatin methacrylate (GelMA), alginate, and collagen-based gels

✅ Pros:

• Supports both injectable gel formation and in situ 3D bioprinting applications.
• Compatible with cells, customizable viscosity, and UV or ionic crosslinking for on-demand setting.
• Self-healing hydrogel R&D in collaboration with academic partners.

📈 Future Growth Prospects:

With the integration into 3D Systems, Allevi is enhancing its platform for tissue printing and regenerative scaffold development, including implantable gel-based structures and on-demand hydrogel synthesis.

---

4. Fidia Pharma USA Inc.

Headquarters: Parsippany, NJ
Parent Company: Fidia Farmaceutici (Italy)

🔬 Main Product Line:

• Hymovis® and Hyalgan® – Injectable hyaluronic acid (HA)-based hydrogels for osteoarthritis and joint health

✅ Pros:

• Viscoelastic, biodegradable HA-based gel with proven anti-inflammatory effects.
• Long-lasting joint lubrication with a dual-action mechanism (residence time + mechanical support).
• CE- and FDA-cleared for human use.

📈 Future Growth Prospects:

With a strong focus on regenerative orthopedics and rheumatology, Fidia is expanding into next-gen HA gels for drug delivery, ophthalmology, and cosmetic applications. Their injectable hydrogel expertise positions them well in aging populations and chronic joint diseases.

---

5. Axelgaard Manufacturing Co., Ltd.

Headquarters: Fallbrook, CA

🔬 Main Product Line:

• Hydrogel adhesives and bioelectrode interfaces (e.g., ValuTrode®, UltraStim®)
• Now developing hydrogel patches with embedded drug or gene delivery functionality

✅ Pros:

• Pioneers in electroconductive hydrogels, ideal for neural interfaces and therapeutic patches.
• Long-lasting adhesion, biocompatibility, and moisture-locking properties.
• Customizable formulations for electrical stimulation, diagnostics, and biofeedback.

📈 Future Growth Prospects:

Axelgaard is expanding its IP into smart wearable hydrogels, enabling responsive, feedback-controlled drug delivery and bioelectronic medicine. This aligns with booming demand in digital health and remote diagnostics.

---

6. Tissium (U.S. Expansion)

U.S. Collaborations & Offices: Boston, MA
Headquarters: Paris, France

🔬 Main Product Line:

• Tissium Sealant Platform – Injectable, light-activated hydrogel sealants for nerve, cardiovascular, and gastrointestinal applications

✅ Pros:

• Amphiphilic copolymer-based injectable hydrogel that sets rapidly with UV light activation.
• Self-healing, stretchable, and adhesive even to wet tissue, enabling leak-proof surgical repair.
• Designed for nerve regeneration, vascular closure, and internal tissue adhesion.

📈 Future Growth Prospects:

Tissium is one of the most innovative players in smart, functionalized hydrogels. With multiple clinical programs underway and strong venture backing, the company is poised to disrupt surgical adhesives and bio-integration of implants.

---

7. Advanced Solutions Life Sciences (ASLS)

Headquarters: Louisville, KY

🔬 Main Product Line:

• Tissue Structure Information Modeling (TSIM®) and BioAssemblyBot® with custom hydrogel blends
• Injectable and printable hydrogels based on collagen, fibrin, PEG, and ECM mimetics

✅ Pros:

• Their injectable hydrogels are designed to mimic natural ECM, support angiogenesis, and promote integration with host tissue.
• Integrated with robotic precision tools for on-site, in situ tissue creation.
• Supports cell encapsulation and drug release.

📈 Future Growth Prospects:

ASLS is pushing the boundaries of dynamic tissue modeling and biomanufacturing, combining hydrogels with AI-guided robotic systems. Their injectable ECM gels are promising for organ-on-chip systems, tumor modeling, and implantable grafts.

---

🧠 Why Injectable and Self-Healing Hydrogels Matter

These materials are designed to adapt to biological environments, making them invaluable for applications such as:

• Minimally invasive surgeries
• Targeted drug delivery systems
• Soft tissue engineering and regeneration
• Wound sealing and internal adhesives
• Cell and gene therapy scaffolds

Their biocompatibility, flexibility, and smart response capabilities allow engineers and clinicians to create patient-specific therapies with high precision and fewer complications.

---

📬 Submit Your Company or Technology

Do you work with a startup or established company advancing hydrogel technologies for medicine?
Submit your listing today at BioMedEngineerDirectory.com — we’re building the most comprehensive biomedical innovation map online.

---

🎥 Want to Learn More?

Subscribe to our YouTube Channel for in-depth videos, material demos, and interviews with leaders in biomaterials, regenerative medicine, and biofabrication.

📬 Have Questions or Ideas?
We’d love to hear from you! Whether you’re a student, educator, or industry professional, feel free to contact us with your questions, suggestions, or collaboration opportunities.